Healthy Options: study protocol and baseline characteristics for a cluster randomized controlled trial of group psychotherapy for perinatal women living with HIV and depression in Tanzania

Table 3 Primary and secondary outcomes for the randomized controlled trial at baseline (n = 742)

	Control n = 347	Intervention n = 395
Depression (possible range 1–27; mean, SD)^a	11.6 (3.0)	11.3 (3.2)
Any intimate partner violence^b	53 (17.4%)	59 (16.3%)
Social support scale (range 1–4; mean, SD)^c	3.0 (0.7)	2.9 (0.7)
Self-efficacy scale (range 1–4; mean, SD)^c	3.1 (0.6)	3.1 (0.8)
Hope scale (range 1–4; mean, SD)^c	3.5 (0.4)	3.5 (0.4)
HIV-related stigma scale (range 1–5; mean, SD)^d,e	2.2 (0.7)	2.0 (0.7)
Missed one or more days of ART in past 4 days	44 (13.3%)	58 (14.7%)

the N for individual questions may differ from the overall N due to question non-response or, where noted, due to eligibility to answer the question
^aLower values are better; women were screened prior to enrollment and eligible if their score on the screening survey was 9 or higher
^b659 women (305 in control facilities and 363 in intervention facilities) reported being in an intimate partner relationship and/or chose to answer this question
^cHigher values are better
^dLower values are better
^e548 women reported disclosing their HIV status to anyone; n for this scale is 484

ISSN: 1471-2458